The study met its primary endpoint of radiographic progression free survival, which was significantly prolonged with the ...
Rarely has a footnote garnered so much positive attention, but a reference in the newly updated prostate cancer guidelines from the National Comprehensive Cancer Network (NCCN) has prostate cancer ...
The 2026 PSMA & Beyond conference featured a clinical development session and presentation by Dr. Jeremie Calais discussing a review of phase 1/2 compounds recently published. Without question, there ...
Impact of BRCA alterations on androgen receptor pathway inhibition treatment outcome in advanced prostate cancer. Predictive associations between serum dehydroepiandrosterone sulfate (DHEAS) and race ...
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...
Prostate-specific membrane antigen (PSMA) is a leading target for next-generation prostate cancer therapies, with one FDA-approved medicine and 30 medicines in development Quantitative PSMA-PET ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results